{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:47:29Z","timestamp":1787003249131,"version":"build-2736575974"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Type 1 diabetes (T1D) is a progressive autoimmune condition that culminates in loss of insulin-producing beta cells. Pancreatic histopathology provides essential insights into disease initiation\/progression yet an integrated perspective onto in situ pathogenic processes is lacking. Here, we combined multiplexed immunostaining, high-magnification whole-slide imaging, digital pathology, and semi-automated image analyses to interrogate pancreatic tail and head sections across T1D stages, including at-risk and at-onset cases. Deconvolution of architectural features, endocrine cell composition, immune cell burden, and spatial relations of ~25,000 islets effectively contextualizes previously established and additional pancreatic hallmarks in health and T1D. Our results reveal a spatially homogenous and islet size-contingent architectural organization of the endocrine pancreas, a notable coordination of organ-wide pathogenic processes, and multiple histopathological correlates that foreshadow distinctive T1D histopathology already at the preclinical stage. Altogether, we propose a revised natural history of T1D with implications for further histopathological investigations and considerations of pathogenetic modalities.<\/jats:p>","DOI":"10.1038\/s41467-026-68610-1","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:55:44Z","timestamp":1770832544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integrated histopathology of the human pancreas throughout stages of type 1 diabetes progression"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3602-4405","authenticated-orcid":false,"given":"Verena","family":"van der Heide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3795-3772","authenticated-orcid":false,"given":"Sara","family":"McArdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0480-5597","authenticated-orcid":false,"given":"Michael S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7403-6239","authenticated-orcid":false,"given":"Karen","family":"Cerosaletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-9520","authenticated-orcid":false,"given":"Sacha","family":"Gnjatic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Mikulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-0958","authenticated-orcid":false,"given":"Amanda L.","family":"Posgai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2614-0813","authenticated-orcid":false,"given":"Irina","family":"Kusmartseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-4782","authenticated-orcid":false,"given":"Mark A.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7622-5754","authenticated-orcid":false,"given":"Dirk","family":"Homann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"68610_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383, 69\u201382 (2014).","journal-title":"Lancet"},{"key":"68610_CR2","doi-asserted-by":"crossref","unstructured":"Powers, A. C. Type 1 diabetes mellitus: much progress, many opportunities. J. Clin. Investig. 131, e142242 (2021).","DOI":"10.1172\/JCI142242"},{"key":"68610_CR3","unstructured":"Redondo, M. J., Onengut-Gumuscu, S., & Gaulton, K. J. Genetics of type 1 diabetes. in Diabetes in America (eds Lawrence J. M., Casagrande S. S., Herman W. H., Wexler D. J., & Cefalu W. T.) (2023)."},{"key":"68610_CR4","unstructured":"Stene, L. C., Norris, J. M., & Rewers, M. J. Risk factors for type 1 diabetes. In: Diabetes in America (eds Lawrence J. M., Casagrande S. S., Herman W. H., Wexler D. J., Cefalu W. T.) (National Library of Medicine, 2023)."},{"key":"68610_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41577-023-00985-4","volume":"24","author":"KC Herold","year":"2024","unstructured":"Herold, K. C. et al. The immunology of type 1 diabetes. Nat. Rev. Immunol. 24, 435\u2013451 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"68610_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","volume":"17","author":"BO Roep","year":"2021","unstructured":"Roep, B. O., Thomaidou, S., van Tienhoven, R. & Zaldumbide, A. Type 1 diabetes mellitus as a disease of the beta-cell (do not blame the immune system?). Nat. Rev. Endocrinol. 17, 150\u2013161 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"68610_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41574-023-00826-3","volume":"19","author":"DL Eizirik","year":"2023","unstructured":"Eizirik, D. L., Szymczak, F. & Mallone, R. Why does the immune system destroy pancreatic beta-cells but not alpha-cells in type 1 diabetes? Nat. Rev. Endocrinol. 19, 425\u2013434 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"68610_CR8","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.cmet.2023.06.018","volume":"35","author":"MA Atkinson","year":"2023","unstructured":"Atkinson, M. A. & Mirmira, R. G. The pathogenic \u201csymphony\u201d in type 1 diabetes: a disorder of the immune system, beta cells, and exocrine pancreas. Cell Metab. 35, 1500\u20131518 (2023).","journal-title":"Cell Metab."},{"key":"68610_CR9","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel, R. A. et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diab. Care 38, 1964\u20131974 (2015).","journal-title":"Diab. Care"},{"key":"68610_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2337\/diabetes.50.2.217","volume":"50","author":"EA Gale","year":"2001","unstructured":"Gale, E. A. The discovery of type 1 diabetes. Diabetes 50, 217\u2013226 (2001).","journal-title":"Diabetes"},{"key":"68610_CR11","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1007\/s00125-016-4067-4","volume":"59","author":"SJ Richardson","year":"2016","unstructured":"Richardson, S. J. et al. Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes. Diabetologia 59, 2448\u20132458 (2016).","journal-title":"Diabetologia"},{"key":"68610_CR12","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1530\/JOE-21-0358","volume":"252","author":"SJ Richardson","year":"2021","unstructured":"Richardson, S. J. & Pugliese, A. 100 YEARS OF INSULIN: Pancreas pathology in type 1 diabetes: an evolving story. J. Endocrinol. 252, R41\u2013R57 (2021).","journal-title":"J. Endocrinol."},{"key":"68610_CR13","doi-asserted-by":"crossref","unstructured":"Cantley, J., Eizirik, D. L., Latres, E., & Dayan, C. M. Islet cells in human type 1 diabetes: from recent advances to novel therapies\u2014a symposium-based roadmap for future research. J. Endocrinol. 259, e230082 (2023).","DOI":"10.1530\/JOE-23-0082"},{"key":"68610_CR14","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.celrep.2018.02.032","volume":"22","author":"M Brissova","year":"2018","unstructured":"Brissova, M. et al. alpha cell function and gene expression are compromised in type 1 diabetes. Cell Rep. 22, 2667\u20132676 (2018).","journal-title":"Cell Rep."},{"key":"68610_CR15","doi-asserted-by":"crossref","unstructured":"Dos Santos, T. et al. Altered immune and metabolic molecular pathways drive islet cell dysfunction in human type 1 diabetes. J. Clin. Investig. 135, e195267 (2025).","DOI":"10.1172\/JCI195267"},{"key":"68610_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/db15-0779","volume":"65","author":"M Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson, M. et al. Insulitis and beta-cell mass in the natural history of type 1 diabetes. Diabetes 65, 719\u2013731 (2016).","journal-title":"Diabetes"},{"key":"68610_CR17","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.2337\/db16-1343","volume":"66","author":"T Rodriguez-Calvo","year":"2017","unstructured":"Rodriguez-Calvo, T. et al. Increase in pancreatic proinsulin and preservation of beta cell mass in autoantibody positive donors prior to type 1 diabetes onset. Diabetes 66, 1334\u20131345 (2017).","journal-title":"Diabetes"},{"key":"68610_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108320","volume":"211","author":"S Rajendran","year":"2020","unstructured":"Rajendran, S. et al. IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes. Clin. Immunol. 211, 108320 (2020).","journal-title":"Clin. Immunol."},{"key":"68610_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2337\/db19-0554","volume":"69","author":"I Kusmartseva","year":"2020","unstructured":"Kusmartseva, I. et al. Temporal analysis of amylase expression in control, autoantibody-positive, and type 1 diabetes pancreatic tissues. Diabetes 69, 60\u201366 (2020).","journal-title":"Diabetes"},{"key":"68610_CR20","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","volume":"32","author":"I Kusmartseva","year":"2020","unstructured":"Kusmartseva, I. et al. Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19. Cell Metab. 32, 1041\u20131051.e1046 (2020).","journal-title":"Cell Metab."},{"key":"68610_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ajpath.2020.11.010","volume":"191","author":"X Tang","year":"2021","unstructured":"Tang, X. et al. Image-based machine learning algorithms for disease characterization in the human type 1 diabetes pancreas. Am. J. Pathol. 191, 454\u2013462 (2021).","journal-title":"Am. J. Pathol."},{"key":"68610_CR22","doi-asserted-by":"crossref","unstructured":"Apaolaza, P. S. et al. Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes. Sci Adv. 7, eabd6527 (2021).","DOI":"10.1126\/sciadv.abd6527"},{"key":"68610_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.689799","volume":"8","author":"PS Apaolaza","year":"2021","unstructured":"Apaolaza, P. S., Petropoulou, P. I. & Rodriguez-Calvo, T. Whole-slide image analysis of human pancreas samples to elucidate the immunopathogenesis of type 1 diabetes using the QuPath software. Front Mol. Biosci. 8, 689799 (2021).","journal-title":"Front Mol. Biosci."},{"key":"68610_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00125-021-05619-9","volume":"65","author":"E Quesada-Masachs","year":"2022","unstructured":"Quesada-Masachs, E. et al. Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes. Diabetologia 65, 387\u2013401 (2022).","journal-title":"Diabetologia"},{"key":"68610_CR25","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00125-023-05888-6","volume":"66","author":"PS Apaolaza","year":"2023","unstructured":"Apaolaza, P. S., Balcacean, D., Zapardiel-Gonzalo, J. & Rodriguez-Calvo, T. The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes. Diabetologia 66, 1129\u20131141 (2023).","journal-title":"Diabetologia"},{"key":"68610_CR26","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2337\/db23-0009","volume":"73","author":"JJ Wright","year":"2024","unstructured":"Wright, J. J. et al. Exocrine pancreas in type 1 and type 2 diabetes: different patterns of fibrosis, metaplasia, angiopathy, and adiposity. Diabetes 73, 1140\u20131152 (2024).","journal-title":"Diabetes"},{"key":"68610_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55908-9","volume":"16","author":"A Carre","year":"2025","unstructured":"Carre, A. et al. Interferon-alpha promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic beta-cells. Nat. Commun. 16, 765 (2025).","journal-title":"Nat. Commun."},{"key":"68610_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cmet.2018.11.014","volume":"29","author":"N Damond","year":"2019","unstructured":"Damond, N. et al. A map of human type 1 diabetes progression by imaging mass cytometry. Cell Metab. 29, 755\u2013768 (2019).","journal-title":"Cell Metab."},{"key":"68610_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cmet.2019.01.003","volume":"29","author":"YJ Wang","year":"2019","unstructured":"Wang, Y. J. et al. Multiplexed in situ imaging mass cytometry analysis of the human endocrine pancreas and immune system in type 1 diabetes. Cell Metab. 29, 769\u2013783 (2019).","journal-title":"Cell Metab."},{"key":"68610_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s42255-022-00531-x","volume":"4","author":"M Fasolino","year":"2022","unstructured":"Fasolino, M. et al. Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes. Nat. Metab. 4, 284\u2013299 (2022).","journal-title":"Nat. Metab."},{"key":"68610_CR31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41586-023-06693-2","volume":"624","author":"JT Walker","year":"2023","unstructured":"Walker, J. T. et al. Genetic risk converges on regulatory networks mediating early type 2 diabetes. Nature 624, 621\u2013629 (2023).","journal-title":"Nature"},{"key":"68610_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47334-0","volume":"15","author":"A Mongia","year":"2024","unstructured":"Mongia, A. et al. AnnoSpat annotates cell types and quantifies cellular arrangements from spatial proteomics. Nat. Commun. 15, 3744 (2024).","journal-title":"Nat. Commun."},{"key":"68610_CR33","doi-asserted-by":"crossref","unstructured":"Barlow, G. L. et al. The extra-islet pancreas supports autoimmunity in human type 1 diabetes. eLife 13, RP100535 (2025).","DOI":"10.7554\/eLife.100535"},{"key":"68610_CR34","doi-asserted-by":"crossref","unstructured":"Steenbuck, N. et al. Imaging mass cytometry reveals early \u03b2-cell dysfunction and changes in immune signatures during type 1 diabetes progression in human pancreata. bioRxiv (2025).","DOI":"10.1101\/2025.03.05.641526"},{"key":"68610_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47686-7","volume":"15","author":"J Lehrstrand","year":"2024","unstructured":"Lehrstrand, J. et al. Illuminating the complete beta-cell mass of the human pancreas\u2014signifying a new view on the islets of Langerhans. Nat. Commun. 15, 3318 (2024).","journal-title":"Nat. Commun."},{"key":"68610_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114346","volume":"43","author":"DM Drotar","year":"2024","unstructured":"Drotar, D. M. et al. Impaired islet function and normal exocrine enzyme secretion occur with low inter-regional variation in type 1 diabetes. Cell Rep. 43, 114346 (2024).","journal-title":"Cell Rep."},{"key":"68610_CR37","doi-asserted-by":"crossref","unstructured":"Rippa, A. et al. 3D imaging of human pancreas suggests islet size and endocrine composition influence their loss in type 1 diabetes. Nat. Commun. 16, 11379 (2025).","DOI":"10.1038\/s41467-025-66198-6"},{"key":"68610_CR38","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2337\/db22-0097","volume":"71","author":"ALJ Carr","year":"2022","unstructured":"Carr, A. L. J. et al. Circulating C-peptide levels in living children and young people and pancreatic beta-cell loss in pancreas donors across type 1 diabetes disease duration. Diabetes 71, 1591\u20131596 (2022).","journal-title":"Diabetes"},{"key":"68610_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15155","volume":"40","author":"F Torabi","year":"2023","unstructured":"Torabi, F. et al. Differential expression of genes controlling lymphocyte differentiation and migration in two distinct endotypes of type 1 diabetes. Diabet. Med 40, e15155 (2023).","journal-title":"Diabet. Med"},{"key":"68610_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00125-022-05818-y","volume":"66","author":"MJ Redondo","year":"2023","unstructured":"Redondo, M. J. et al. Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. Diabetologia 66, 127\u2013131 (2023).","journal-title":"Diabetologia"},{"key":"68610_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/jpi.jpi_82_18","volume":"10","author":"F Aeffner","year":"2019","unstructured":"Aeffner, F. et al. Introduction to digital image analysis in whole-slide imaging: a white paper from the digital pathology association. J. Pathol. Inf. 10, 9 (2019).","journal-title":"J. Pathol. Inf."},{"key":"68610_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"68610_CR43","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/path.5921","volume":"257","author":"P Bankhead","year":"2022","unstructured":"Bankhead, P. Developing image analysis methods for digital pathology. J. Pathol. 257, 391\u2013402 (2022).","journal-title":"J. Pathol."},{"key":"68610_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102708","volume":"123","author":"S Rajendran","year":"2021","unstructured":"Rajendran, S. et al. IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes. J. Autoimmun. 123, 102708 (2021).","journal-title":"J. Autoimmun."},{"key":"68610_CR45","doi-asserted-by":"publisher","first-page":"aaf6925","DOI":"10.1126\/sciimmunol.aaf6925","volume":"1","author":"R Remark","year":"2016","unstructured":"Remark, R. et al. In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide. Sci. Immunol. 1, aaf6925 (2016).","journal-title":"Sci. Immunol."},{"key":"68610_CR46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/978-1-4939-9773-2_23","volume":"2055","author":"G Akturk","year":"2020","unstructured":"Akturk, G., Sweeney, R., Remark, R., Merad, M. & Gnjatic, S. Multiplexed immunohistochemical consecutive staining on single slide (MICSSS): multiplexed chromogenic IHC assay for high-dimensional tissue analysis. Methods Mol. Biol. 2055, 497\u2013519 (2020).","journal-title":"Methods Mol. Biol."},{"key":"68610_CR47","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1158\/1078-0432.CCR-21-2051","volume":"27","author":"G Akturk","year":"2021","unstructured":"Akturk, G. et al. Multiplex tissue imaging harmonization: a multicenter experience from CIMAC-CIDC immuno-oncology biomarkers network. Clin. Cancer Res. 27, 5072\u20135083 (2021).","journal-title":"Clin. Cancer Res."},{"key":"68610_CR48","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","volume":"29","author":"A Magen","year":"2023","unstructured":"Magen, A. et al. Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nat. Med. 29, 1389\u20131399 (2023).","journal-title":"Nat. Med."},{"key":"68610_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-023-06797-9","volume":"625","author":"NM LaMarche","year":"2024","unstructured":"LaMarche, N. M. et al. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis. Nature 625, 166\u2013174 (2024).","journal-title":"Nature"},{"key":"68610_CR50","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1007\/s00125-020-05155-y","volume":"63","author":"JJ Wright","year":"2020","unstructured":"Wright, J. J. et al. Decreased pancreatic acinar cell number in type 1 diabetes. Diabetologia 63, 1418\u20131423 (2020).","journal-title":"Diabetologia"},{"key":"68610_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-04471-w","volume":"15","author":"A Tegehall","year":"2025","unstructured":"Tegehall, A. et al. Islet delta-cell architecture is remodelled in the human pancreas during type 1 diabetes. Sci. Rep. 15, 19776 (2025).","journal-title":"Sci. Rep."},{"key":"68610_CR52","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/cjp2.140","volume":"5","author":"P Seiron","year":"2019","unstructured":"Seiron, P. et al. Characterisation of the endocrine pancreas in type 1 diabetes: islet size is maintained but islet number is markedly reduced. J. Pathol. Clin. Res. 5, 248\u2013255 (2019).","journal-title":"J. Pathol. Clin. Res."},{"key":"68610_CR53","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0092-8674(85)90124-2","volume":"42","author":"L Orci","year":"1985","unstructured":"Orci, L. et al. Direct identification of prohormone conversion site in insulin-secreting cells. Cell 42, 671\u2013681 (1985).","journal-title":"Cell"},{"key":"68610_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/dom.13378","volume":"20","author":"M Liu","year":"2018","unstructured":"Liu, M. et al. Biosynthesis, structure, and folding of the insulin precursor protein. Diab. Obes. Metab. 20, 28\u201350 (2018).","journal-title":"Diab. Obes. Metab."},{"key":"68610_CR55","doi-asserted-by":"crossref","unstructured":"Stevens, M. et al. StarDist image segmentation improves circulating tumor cell detection. Cancers 14, 2916 (2022).","DOI":"10.3390\/cancers14122916"},{"key":"68610_CR56","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF01236270","volume":"17","author":"F Malaisse-Lagae","year":"1979","unstructured":"Malaisse-Lagae, F., Stefan, Y., Cox, J., Perrelet, A. & Orci, L. Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide. Diabetologia 17, 361\u2013365 (1979).","journal-title":"Diabetologia"},{"key":"68610_CR57","doi-asserted-by":"publisher","first-page":"e55501","DOI":"10.1371\/journal.pone.0055501","volume":"8","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Quantitative analysis of pancreatic polypeptide cell distribution in the human pancreas. PLoS One 8, e55501 (2013).","journal-title":"PLoS One"},{"key":"68610_CR58","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1369\/0022155415583535","volume":"63","author":"MF Brereton","year":"2015","unstructured":"Brereton, M. F., Vergari, E., Zhang, Q. & Clark, A. Alpha-, delta- and PP-cells: Are they the architectural cornerstones of islet structure and co-ordination? J. Histochem. Cytochem. Off J. Histochem. Soc. 63, 575\u2013591 (2015).","journal-title":"J. Histochem. Cytochem. Off J. Histochem. Soc."},{"key":"68610_CR59","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00125-013-2896-y","volume":"56","author":"P Achenbach","year":"2013","unstructured":"Achenbach, P. et al. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia 56, 1615\u20131622 (2013).","journal-title":"Diabetologia"},{"key":"68610_CR60","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2337\/dc18-1785","volume":"42","author":"SA Sharp","year":"2019","unstructured":"Sharp, S. A. et al. Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diab. Care 42, 200\u2013207 (2019).","journal-title":"Diab. Care"},{"key":"68610_CR61","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2337\/dc18-1727","volume":"42","author":"S Onengut-Gumuscu","year":"2019","unstructured":"Onengut-Gumuscu, S. et al. Type 1 diabetes risk in african-ancestry participants and utility of an ancestry-specific genetic risk score. Diab. Care 42, 406\u2013415 (2019).","journal-title":"Diab. Care"},{"key":"68610_CR62","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/hmg\/ddae024","volume":"33","author":"DA Michalek","year":"2024","unstructured":"Michalek, D. A. et al. A multi-ancestry genome-wide association study in type 1 diabetes. Hum. Mol. Genet. 33, 958\u2013968 (2024).","journal-title":"Hum. Mol. Genet."},{"key":"68610_CR63","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00125-015-3752-z","volume":"59","author":"ML Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson, M. L. et al. The influence of type 1 diabetes on pancreatic weight. Diabetologia 59, 217\u2013221 (2016).","journal-title":"Diabetologia"},{"key":"68610_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0653-y","volume":"15","author":"M Campbell-Thompson","year":"2015","unstructured":"Campbell-Thompson, M., Rodriguez-Calvo, T. & Battaglia, M. Abnormalities of the exocrine pancreas in type 1 diabetes. Curr. Diab. Rep. 15, 79 (2015).","journal-title":"Curr. Diab. Rep."},{"key":"68610_CR65","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1210\/endrev\/bnab010","volume":"42","author":"JT Walker","year":"2021","unstructured":"Walker, J. T., Saunders, D. C., Brissova, M. & Powers, A. C. The human islet: mini-organ with mega-impact. Endocr. Rev. 42, 605\u2013657 (2021).","journal-title":"Endocr. Rev."},{"key":"68610_CR66","doi-asserted-by":"publisher","first-page":"e67454","DOI":"10.1371\/journal.pone.0067454","volume":"8","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Regional differences in islet distribution in the human pancreas-preferential beta-cell loss in the head region in patients with type 2 diabetes. PLoS ONE 8, e67454 (2013).","journal-title":"PLoS ONE"},{"key":"68610_CR67","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/s42255-024-01114-8","volume":"6","author":"M Perez-Frances","year":"2024","unstructured":"Perez-Frances, M. et al. Regulated and adaptive in vivo insulin secretion from islets only containing beta-cells. Nat. Metab. 6, 1791\u20131806 (2024).","journal-title":"Nat. Metab."},{"key":"68610_CR68","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1093\/hmg\/ddz094","volume":"28","author":"N Jeffery","year":"2019","unstructured":"Jeffery, N., Richardson, S., Chambers, D., Morgan, N. G. & Harries, L. W. Cellular stressors may alter islet hormone cell proportions by moderation of alternative splicing patterns. Hum. Mol. Genet. 28, 2763\u20132774 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"68610_CR69","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.2337\/dbi20-0034","volume":"70","author":"T Rodriguez-Calvo","year":"2021","unstructured":"Rodriguez-Calvo, T. et al. Altered beta-Cell Prohormone Processing and Secretion in Type 1 Diabetes. Diabetes 70, 1038\u20131050 (2021).","journal-title":"Diabetes"},{"key":"68610_CR70","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4161\/isl.18660","volume":"4","author":"J Jo","year":"2012","unstructured":"Jo, J., Hara, M., Ahlgren, U., Sorenson, R. & Periwal, V. Mathematical models of pancreatic islet size distributions. Islets 4, 10\u201319 (2012).","journal-title":"Islets"},{"key":"68610_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/srep14634","volume":"5","author":"C Ionescu-Tirgoviste","year":"2015","unstructured":"Ionescu-Tirgoviste, C. et al. A 3D map of the islet routes throughout the healthy human pancreas. Sci. Rep. 5, 14634 (2015).","journal-title":"Sci. Rep."},{"key":"68610_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/srep34049","volume":"6","author":"A Poudel","year":"2016","unstructured":"Poudel, A., Fowler, J. L., Zielinski, M. C., Kilimnik, G. & Hara, M. Stereological analyses of the whole human pancreas. Sci. Rep. 6, 34049 (2016).","journal-title":"Sci. Rep."},{"key":"68610_CR73","doi-asserted-by":"crossref","unstructured":"Da Silva Xavier G. The Cells of the Islets of Langerhans. J Clin Med 7, (2018).","DOI":"10.3390\/jcm7030054"},{"key":"68610_CR74","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/db19-0072","volume":"68","author":"MP Dybala","year":"2019","unstructured":"Dybala, M. P. & Hara, M. Heterogeneity of the Human Pancreatic Islet. Diabetes 68, 1230\u20131239 (2019).","journal-title":"Diabetes"},{"key":"68610_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1620\/tjem.149.1","volume":"149","author":"T Kaihoh","year":"1986","unstructured":"Kaihoh, T., Masuda, T., Sasano, N. & Takahashi, T. The size and number of Langerhans islets correlated with their endocrine function: a morphometry on immunostained serial sections of adult human pancreases. Tohoku J. Exp. Med. 149, 1\u201310 (1986).","journal-title":"Tohoku J. Exp. Med."},{"key":"68610_CR76","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4161\/isl.19256","volume":"4","author":"G Kilimnik","year":"2012","unstructured":"Kilimnik, G., Jo, J., Periwal, V., Zielinski, M. C. & Hara, M. Quantification of islet size and architecture. Islets 4, 167\u2013172 (2012).","journal-title":"Islets"},{"key":"68610_CR77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2019","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38\u201344 (2019).","journal-title":"Nat. Biotechnol."},{"key":"68610_CR78","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1177\/0963689718779898","volume":"27","author":"HH Huang","year":"2018","unstructured":"Huang, H. H., Harrington, S. & Stehno-Bittel, L. The flaws and future of islet volume measurements. Cell Transpl. 27, 1017\u20131026 (2018).","journal-title":"Cell Transpl."},{"key":"68610_CR79","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00125-013-3043-5","volume":"56","author":"ML Campbell-Thompson","year":"2013","unstructured":"Campbell-Thompson, M. L. et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia 56, 2541\u20132543 (2013).","journal-title":"Diabetologia"},{"key":"68610_CR80","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.2337\/db14-0549","volume":"63","author":"T Rodriguez-Calvo","year":"2014","unstructured":"Rodriguez-Calvo, T., Ekwall, O., Amirian, N., Zapardiel-Gonzalo, J. & von Herrath, M. G. Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63, 3880\u20133890 (2014).","journal-title":"Diabetes"},{"key":"68610_CR81","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","volume":"63","author":"P Leete","year":"2020","unstructured":"Leete, P. et al. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia 63, 1258\u20131267 (2020).","journal-title":"Diabetologia"},{"key":"68610_CR82","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2337\/db15-1615","volume":"65","author":"P Leete","year":"2016","unstructured":"Leete, P. et al. Differential insulitic profiles determine the extent of beta-cell destruction and the age at onset of type 1 diabetes. Diabetes 65, 1362\u20131369 (2016).","journal-title":"Diabetes"},{"key":"68610_CR83","doi-asserted-by":"crossref","unstructured":"Culina, S. et al. Islet-reactive CD8(+) T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci. Immunol. 3, eaao4013 (2018).","DOI":"10.1126\/sciimmunol.aao4013"},{"key":"68610_CR84","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/MED.0b013e32835edb89","volume":"20","author":"O Skog","year":"2013","unstructured":"Skog, O., Korsgren, S., Melhus, A. & Korsgren, O. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr. Opin. Endocrinol. Diab. Obes. 20, 118\u2013123 (2013).","journal-title":"Curr. Opin. Endocrinol. Diab. Obes."},{"key":"68610_CR85","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","volume":"127","author":"A Pugliese","year":"2017","unstructured":"Pugliese, A. Autoreactive T cells in type 1 diabetes. J. Clin. Investig. 127, 2881\u20132891 (2017).","journal-title":"J. Clin. Investig."},{"key":"68610_CR86","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4161\/isl.24780","volume":"5","author":"B Farhat","year":"2013","unstructured":"Farhat, B. et al. Small human islets comprised of more beta-cells with higher insulin content than large islets. Islets 5, 87\u201394 (2013).","journal-title":"Islets"},{"key":"68610_CR87","doi-asserted-by":"publisher","first-page":"594","DOI":"10.2337\/db06-0779","volume":"56","author":"R Lehmann","year":"2007","unstructured":"Lehmann, R. et al. Superiority of small islets in human islet transplantation. Diabetes 56, 594\u2013603 (2007).","journal-title":"Diabetes"},{"key":"68610_CR88","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvae002","volume":"190","author":"NG Morgan","year":"2024","unstructured":"Morgan, N. G. Insulitis in human type 1 diabetes: lessons from an enigmatic lesion. Eur. J. Endocrinol. 190, R1\u2013R9 (2024).","journal-title":"Eur. J. Endocrinol."},{"key":"68610_CR89","doi-asserted-by":"publisher","first-page":"e1009900","DOI":"10.1371\/journal.pcbi.1009900","volume":"18","author":"C Wilson","year":"2022","unstructured":"Wilson, C. et al. Tumor immune cell clustering and its association with survival in African American women with ovarian cancer. PLoS Comput. Biol. 18, e1009900 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"68610_CR90","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.smallrumres.2016.05.012","volume":"140","author":"G Molina","year":"2016","unstructured":"Molina, G. et al. Spatial structure of skin follicles in Suri and Huacaya alpacas. Small Rumin. Res. 140, 22\u201326 (2016).","journal-title":"Small Rumin. Res."},{"key":"68610_CR91","doi-asserted-by":"publisher","first-page":"036009","DOI":"10.1088\/1478-3975\/10\/3\/036009","volume":"10","author":"J Jo","year":"2013","unstructured":"Jo, J. et al. The fractal spatial distribution of pancreatic islets in three dimensions: a self-avoiding growth model. Phys. Biol. 10, 036009 (2013).","journal-title":"Phys. Biol."},{"key":"68610_CR92","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0891-0618(00)00064-8","volume":"20","author":"C Duyckaerts","year":"2000","unstructured":"Duyckaerts, C. & Godefroy, G. Voronoi tessellation to study the numerical density and the spatial distribution of neurones. J. Chem. Neuroanat. 20, 83\u201392 (2000).","journal-title":"J. Chem. Neuroanat."},{"key":"68610_CR93","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2337\/db09-1855","volume":"59","author":"GS Eisenbarth","year":"2010","unstructured":"Eisenbarth, G. S. Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes. Diabetes 59, 759\u2013774 (2010).","journal-title":"Diabetes"},{"key":"68610_CR94","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2337\/db24-0163","volume":"73","author":"M Martino","year":"2024","unstructured":"Martino, M., Galderisi, A., Evans-Molina, C. & Dayan, C. Revisiting the pattern of loss of beta-cell function in preclinical type 1 diabetes. Diabetes 73, 1769\u20131779 (2024).","journal-title":"Diabetes"},{"key":"68610_CR95","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00592-024-02295-0","volume":"61","author":"L Granlund","year":"2024","unstructured":"Granlund, L., Korsgren, O., Skog, O. & Lundberg, M. Extra-islet cells expressing insulin or glucagon in the pancreas of young organ donors. Acta Diabetol. 61, 1195\u20131203 (2024).","journal-title":"Acta Diabetol."},{"key":"68610_CR96","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-024-03842-4","volume":"486","author":"L Granlund","year":"2024","unstructured":"Granlund, L. & Lundberg, M. Loss of insulin-expressing extra-islet cells in type 1 diabetes is accompanied with increased number of glucagon-expressing extra-islet cells. Virchows Arch. Int. J. Pathol. 486, 687\u2013695 (2024).","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"68610_CR97","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.2337\/db25-0326","volume":"74","author":"DM Drotar","year":"2025","unstructured":"Drotar, D. M. et al. Loss of insulin-positive cell clusters precedes the decrease in islet frequency and beta-cell area in type 1 diabetes. Diabetes 74, 2008\u20132015 (2025).","journal-title":"Diabetes"},{"key":"68610_CR98","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adz2251","volume":"11","author":"K Murrall","year":"2025","unstructured":"Murrall, K. et al. Small things matter: lack of extraislet beta cells in type 1 diabetes. Sci. Adv. 11, eadz2251 (2025).","journal-title":"Sci. Adv."},{"key":"68610_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107523","volume":"31","author":"CR Stoltzfus","year":"2020","unstructured":"Stoltzfus, C. R. et al. CytoMAP: a spatial analysis toolbox reveals features of myeloid cell organization in lymphoid tissues. Cell Rep. 31, 107523 (2020).","journal-title":"Cell Rep."},{"key":"68610_CR100","unstructured":"Dixon, P. M. Ripley\u2019s K function. in Encyclopedia of Environmetrics. (John Wiley & Sons, Ltd., 2002)."},{"key":"68610_CR101","unstructured":"Alexandrov T. ripleyK.m. GitHub https:\/\/github.com\/alexandrovteam\/spatial-corals\/blob\/master\/ripleyK.m (2016)."},{"key":"68610_CR102","unstructured":"Nedbal J. writeFCS(fname, DATA, TEXT, OTHER) Mathworks https:\/\/www.mathworks.com\/matlabcentral\/fileexchange\/42603-writefcs-fname-data-text-other (2024)."},{"key":"68610_CR103","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nature06406","volume":"450","author":"S Nejentsev","year":"2007","unstructured":"Nejentsev, S. et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450, 887\u2013892 (2007).","journal-title":"Nature"},{"key":"68610_CR104","unstructured":"McArdle, S. saramcardle\/MICSSSPancreas: v1.0. Zenodo (2025)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68610-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68610-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68610-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:16:41Z","timestamp":1778645801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68610-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68610"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68610-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6673858\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2025.03.18.644000","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.C. reports other research funding from Cour Pharmaceuticals, IM Therapeutics, GentiBio Inc., and InduPro not related to this study; S.G. reports other research funding from Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Genentech, Regeneron, and Takeda not related to this study; S.G. is a named co-inventor on an issued patent for MICSSS, a multiplex immunohistochemistry technology to characterize tumors and treatment responses that is filed through ISMMS and currently remains unlicensed; all other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4293"}}